Caspase-dependent and -independent suppression of apoptosis by monoHER in Doxorubicin treated cells

Doxorubicin (DOX) is an antitumour agent for different types of cancer, but the dose-related cardiotoxicity limits its clinical use. To prevent this side effect we have developed the flavonoid monohydroxyethylrutoside (monoHER), a promising protective agent, which did not interfere with the antitumo...

Descripción completa

Detalles Bibliográficos
Autores principales: Bruynzeel, A M E, Abou El Hassan, M A, Torun, E, Bast, A, van der Vijgh, W J F, Kruyt, F A E
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2007
Materias:
Translational Therapeutics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2360019/
https://www.ncbi.nlm.nih.gov/pubmed/17285121
http://dx.doi.org/10.1038/sj.bjc.6603598

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2360019/
https://www.ncbi.nlm.nih.gov/pubmed/17285121
http://dx.doi.org/10.1038/sj.bjc.6603598

Ejemplares similares